V2-01.png

Cutting-edge nanotechnology to cure seromas

Seromas affect millions of patients globally

Seromas are wound-like fluid-filled cavities that occur after a variety of surgeries

Especially breast cancer surgery and tissue reconstruction patients are highly affected with seroma rates of 50%-80%. In the best case, affected patients only suffer from pain, limited mobility, and multiple doctor visits. Many patients, however, go through infections, additional surgery, and a delay in cancer therapy delay.

There are more than 3 million patients who suffer from a seroma and its consequences every year.

Our nanoparticles make seromas heal

Our solution features anti-inflammatory, tissue regenerative, and antimicrobial properties

At ETH Zurich and Empa St. Gallen, we have developed mixed metal oxide nanoparticles that stimulate regeneration in close collaboration with leading surgeons in the field. Applied into seromas, they reduce the dead space of the cavity, mimic human enzymes to reduce inflammation, and kill microbes upon contact.

Due to these unique properties, they can also be utilized to support the healing of a wide variety of other wounds and complications.

Our mission

Seromas and poorly healing wounds in general are a massive burden for patients, health care systems, and the economy. An aging society, the rise of diabetes and antibiotic resistances are bound to increase the problem. The last decades have brought little improvement in the field – most products focus on structure restoration or contain expensive biologics.

 

We believe it's time for a change.

 

After decades of research, nanotechnology is mature enough to step into the breach and disrupt the wound care market.

TEAM

We are an interdisciplinary team with backgrounds in nanoscience, engineering, life science, and business administration. Our product is developed in close collaboration with surgeons and leading medical experts.

Co-founder

Dr. Tino MATTER

PhD in Nanomedicine, ETH Zurich and Empa St Gallen

Sebastian Loy Foto Nanoglue

Co-founder

Sebastian LOY

Final year MA Accounting & Finance, HSG

Intern

Elena PRADERVAND

MSc Medical Technology,
ETH Zurich

Emma%2520Dillier%2520Homepage_edited_edi

Intern

Emma DILLIER

MSc Health Sciences & Technology,
ETH Zurich

COLLABORATORS AND ADVISORS

We collaborate with leading scientific and clinical institutions, such as ETH Zurich, Empa, the University Hospital Bern, and the University Hospital Zurich.

 

WHERE TO MEET US

  • Startup DAYs
    Mo., 05. Okt.
    Bern
    05. Okt. 2020, 08:00 – 06. Okt. 2020, 11:00
    Bern, Kursaal Bern
    Deeptech Gathering - STARTUPS | INVESTORS | CORPORATES | ACADEMIA
    Share
2SWISSMEDIC-PORTRAETS-17-5779 Kopie copy_edited_edited.jpg

JÜRG H. SCHNETZER

Former Executive Director Swissmedic
Regulatory advisor

Inge Hermann_edited.jpg

PROF. DR. INGE KATRIN HERRMANN

Translational Science Expert

ETH Zurich | Empa
Scientific advisor

csm_20150312-Constantinescu-Mihai_01_f47

PROF. DR. MIHAI CONSTANTINESCU

Plastic Surgeon

University Hospital Bern 

Clinical advisor

MichaelStucky_iE-Norm-3230_edited.jpg

MICHAEL STUCKY

Successful Life Science Enterpreneur

Business advisor

SUPPORT

 

GET IN TOUCH WITH US

  • linkedin

Thanks for submitting!

Doctor Using Digital Tablet